• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 519-533 of 642 results

2028 Exhibit: ¿¿¿Intranasal Technology, Inc Licenses Aegis Therapeutics IntravailDr...

Document IPR2019-00451, No. 2028-152 Exhibit - ¿¿¿Intranasal Technology, Inc Licenses Aegis Therapeutics IntravailDrug Delivery Technology¿¿¿ Business Wire April 13, 2005 (P.T.A.B. Mar. 10, 2020)

cite Cite Document

1120 Exhibit: Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ, Bioav...

Document IPR2019-00451, No. 1120-124 Exhibit - Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ, Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencin...

cite Cite Document

1110 Exhibit: Wolfe T, Macfarlane T Intranasal midazolam therapy for pediatric stat...

Document IPR2019-00451, No. 1110-114 Exhibit - Wolfe T, Macfarlane T Intranasal midazolam therapy for pediatric status epilepticus Am J Emerg Med 2006 24 343 346 (P.T.A.B. Jan. 28, 2020)

cite Cite Document

1004 Exhibit: Part 8 ¿¿¿ Pages 2451 2681 File History for ¿¿¿546 Patent, Ser No 1349...

Document IPR2019-00451, No. 1004-12 Exhibit - Part 8 ¿¿¿ Pages 2451 2681 File History for ¿¿¿546 Patent, Ser No 13495,942 ¿¿¿546 FH (P.T.A.B. Jan. 29, 2019)

cite Cite Document

1019 Exhibit: Ueda et al, US Patent No 4,657,901, Pharmaceutical Composition, iss...

Document IPR2019-00451, No. 1019-35 Exhibit - Ueda et al, US Patent No 4,657,901, Pharmaceutical Composition, issued April 14, 1987 Ueda (P.T.A.B. Jan. 29, 2019)

cite Cite Document

1004 Exhibit: Part 7 ¿¿¿ Pages 2101 2450 File History for ¿¿¿546 Patent, Ser No 1349...

Document IPR2019-00451, No. 1004-11 Exhibit - Part 7 ¿¿¿ Pages 2101 2450 File History for ¿¿¿546 Patent, Ser No 13495,942 ¿¿¿546 FH (P.T.A.B. Jan. 29, 2019)

cite Cite Document

1007 Exhibit: Part 3 ¿¿¿ Pages 801 1200 File History for Non Provisional Patent Appl...

Document IPR2019-00451, No. 1007-17 Exhibit - Part 3 ¿¿¿ Pages 801 1200 File History for Non Provisional Patent Application Serial No 12413,439, filed March 27, 2009 ¿¿¿439 FH (P.T.A.B. Jan. 29, 2019)

cite Cite Document

1112 Exhibit: Prasad K, Krishman P, Al Roomi K, et al, Anticonvulsant therapy for s...

Document IPR2019-00451, No. 1112-116 Exhibit - Prasad K, Krishman P, Al Roomi K, et al, Anticonvulsant therapy for status epilepticus Br J Clin Pharmacol 2007 63 640 647 (P.T.A.B. Jan. 28, 2020)

cite Cite Document

2016 Exhibit: D Terry et al, ¿¿¿Acceptance of the Use of Diazepam Rectal Gel in Sch...

Document IPR2019-00451, No. 2016-83 Exhibit - D Terry et al, ¿¿¿Acceptance of the Use of Diazepam Rectal Gel in School and Day Care Settings,¿¿¿ Journal of Child Neurology 221135 1138 2007 (P.T.A.B. ...

cite Cite Document

1107 Exhibit: Pang T, Hirsch L Treatment of convulsive and nonconvulsive status e...

Document IPR2019-00451, No. 1107-111 Exhibit - Pang T, Hirsch L Treatment of convulsive and nonconvulsive status epilepticus Cur Treat Options Neurol 2005 7 247 259 (P.T.A.B. Jan. 28, 2020)

cite Cite Document

1150 Exhibit: Declaration of Daniel P Wermeling, PharmD

Document IPR2019-00451, No. 1150-149 Exhibit - Declaration of Daniel P Wermeling, PharmD (P.T.A.B. Jan. 28, 2020)

cite Cite Document

1103 Exhibit: Wang HC, Chang WN, Chang HW, et al Factors predictive of outcome ...

Document IPR2019-00451, No. 1103-107 Exhibit - Wang HC, Chang WN, Chang HW, et al Factors predictive of outcome in posttraumatic seizures J Trauma 2008 64 883 888 (P.T.A.B. Jan. 28, 2020)

cite Cite Document

1148 Exhibit: FDA GUIDANCE FOR INDUSTRY 1999, Applications Covered by Sec...

Document IPR2019-00451, No. 1148-147 Exhibit - FDA GUIDANCE FOR INDUSTRY 1999, Applications Covered by Section 505b2, httpswwwfdagovmedia72419download (P.T.A.B. Jan. 28, 2020)

cite Cite Document

1116 Exhibit: Illum L Is nose to brain transport of drugs a reality JPP 2004 56 3 17

Document IPR2019-00451, No. 1116-120 Exhibit - Illum L Is nose to brain transport of drugs a reality JPP 2004 56 3 17 (P.T.A.B. Jan. 28, 2020)

cite Cite Document

2018 Exhibit: ¿¿¿UCB announces NAYZILAM¿¿ midazolam nasal spray now approved...

Document IPR2019-00451, No. 2018-85 Exhibit - ¿¿¿UCB announces NAYZILAM¿¿ midazolam nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in peop...

cite Cite Document
<< 1 2 3 4 5 ... 35 36 37 38 39 ... >>